Comparative study of interactions between chloroquine and chlorpheniramine or promethazine in healthy volunteers: a potential combination-therapy phenomenon for resuscitating chloroquine for malaria treatment in Africa
Authors:
- G. O. GbotoshoGGG. O. Gbotosho
- C. T. HappiCHC. T. Happi
- A. SijuadeASA. Sijuade
- O. A. T. OgundahunsiOOO. A. T. Ogundahunsi
- A. SowunmiASA. Sowunmi
- A. M. J. OduolaAOA. M. J. Oduola
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 102 (1) , 3-9
Abstract
Although, in in-vitro and limited in-vivo studies, chlorpheniramine (CP) and promethazine (PR) have each been shown to reverse chloroquine (CQ) resistance, the pharmacokinetic basis of this reversal has not been fully elucidated. In the present study, 15 healthy volunteers were randomly allotted to receive standard doses of CQ alone or in combination with CP or PR. Blood samples were collected from each volunteer at 21 time-points, from immediately before to 168 h after the initial dose. These samples were used to follow the changes in the plasma and erythrocytic concentrations of CQ. The ratio between the mean maximum CQ concentration in the erythrocytes and that in the plasma was 4.2 for the volunteers given CQ alone, 7.3 in those given CQ-CP, and 3.2 in those given CQ-PR. CP significantly enhanced the erythrocytic accumulation of CQ, increasing the maximum CQ concentration observed in the erythrocytes by 24% (P = 0.02). The bio-availability of CQ was also significantly increased in the presence of CP, with the mean value for the area under the curve, of erythrocytic concentration v. time, increasing from 99,921 to 214,516 ng/ml.h (P=0.001). The mean half-life of CQ in the erythrocytes also increased when CP was used, from 51 to 100 h, but this change was not statistically significant (P=0.83). In contrast to CP, PR had no statistically significant effect on the disposition of CQ. As CP clearly enhances disposition of CQ, a combination of CQ with CP may be useful in the management of CQ-resistant infections. Detailed toxicological studies are required to understand the full clinical implications of CP's elevation of erythrocytic CQ concentrations.Keywords
This publication has 15 references indexed in Scilit:
- Chemosensitization of Plasmodium falciparum by Probenecid In VitroAntimicrobial Agents and Chemotherapy, 2003
- A CONTRARIAN VIEW OF MALARIA THERAPY POLICY IN AFRICAThe American Journal of Tropical Medicine and Hygiene, 2003
- The Treatment of MalariaNew England Journal of Medicine, 1996
- A Rapid, Cost-Effective Liquid Chromatographic Method for the Determination of Chloroquine and Desethylchloroquine in Biological FluidsTherapeutic Drug Monitoring, 1996
- The potential of desipramine to reverse chloroquine resistance of Plasmodium falciparum is reduced by its binding to plasma proteinTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993
- Reversal of Plasmodium falciparum Resistance to Chloroquine in Panamanian Aotus MonkeysThe American Journal of Tropical Medicine and Hygiene, 1993
- Rapid chloroquine efflux phenotype in both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparumBiochemical Pharmacology, 1992
- Reversal of Chloroquine Resistance in Malaria Parasite Plasmodium falciparum by DesipramineScience, 1988
- Efflux of Chloroquine from Plasmodium falciparum : Mechanism of Chloroquine ResistanceScience, 1987
- Susceptibility of human malaria parasites to chloroquine is pH dependent.Proceedings of the National Academy of Sciences, 1985